Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-07

Clinical Trial Update: Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial is evaluating laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Chicago | Conditions: Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Status: RECRUITING